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Abstract - Omi/HtrA2, a proapoptotic mitochondrial serine protease, is involved in both caspase-dependent and caspase-
independent apoptosis. A growing body of evidence indicates that Omi/HtrA2 plays an important role in the pathogenesis 
of a variety of ischemia/reperfusion (I/R) injuries. However, the role of Omi/HtrA2 in the renal injuries that occur in neo-
nates with asphyxia remains unknown. The present study was designed to investigate whether Omi/HtrA2 plays an impor-
tant role in the types of renal injuries that are induced by neonatal postasphyxial serum. Human renal proximal tubular cell 
line (HK-2) cells were used as targets. A 20% serum taken from neonates one day after asphyxia was applied to the target 
cells as an attacking factor. We initially included control and postasphyxial-serum-attacked groups and later included a 
ucf-101 group in the study. In the postasphyxial-serum-treated group, cytosolic Omi/HtrA2 and caspase-3 expression in 
the HK-2 cells was significantly higher than in the control group. Moreover, the concentration of cytosolic caspase-3 was 
found to be markedly decreased in HK-2 cells in the ucf-101 group. Our results suggest both that postasphyxial serum has 
a potent apoptosis-inducing effect on HK-2 cells and that this effect can be partially blocked by ucf-101. Taken together, 
our results demonstrate for the first time that postasphyxial serum from neonates results in Omi/HtrA2 translocation 
from the mitochondria to the cytosol, where it promotes HK-2 cell apoptosis via a protease activity-dependent, caspase-
mediated pathway.
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INTRODUCTION
Asphyxia is one of the major factors that can cause 
death in neonates during the perinatal period. The 
essence of asphyxia is hypoxia and ischemia, which 
can lead to damage in almost every organ in the 
body. Several studies have indicated that injury to 
the organs of postasphyxial neonates was associated 
with  ischemia/reperfusion.  Neonatal  sequelae,  in 
many cases, may be accounted for by perinatal as-
phyxia damage to organs. As kidneys are very sensi-
tive to oxygen deprivation – renal injury may occur 
within 24 hours of a hypoxic ischemic episode – re-
nal damage has a higher incident rate in asphyxiated 
neonates than any other type of hypoxic-ischemia-
related injury, occurring in more than 50% of neo-
natal asphyxia cases (Gupta et al., 2005). However, 
the precise mechanism of renal injury in postas-
phyxial neonates is still unknown. Understanding 
this mechanism could lead to the development of 
more efficient drugs to prevent newborns undergo-
ing asphyxia from developing renal injury. Omi/
HtrA2 is the mammalian homolog of the prokaryo-
tic HtrA protein. Omi/HtrA2 is a nuclear-encoded 
mitochondrial  serine  protease  and  is  expressed 
generally in almost every tissue and organ of the 1506 YONG ZHANG ET AL.
body (Rami et al., 2010). Omi/HtrA2 is formed as a 
precursor in the cytoplasm, where it is then trans-
located to the mitochondria. In the mitochondria it 
is processed to its mature form via the removal of 
an amino-terminal domain (amino acids 1 to 133), 
which exposes the AVPS motif. Upon induction of 
apoptosis by cellular stresses, mature Omi/HtrA2 is 
released from the mitochondria into the cytoplasm, 
where it binds to the baculovirus IAP repeat domain 
of IAPs via the AVPS sequence motif. Following a 
specific cleavage and degradation of the IAPs, Omi/
HtrA2 initiates caspase-dependent apoptosis. Omi/
HtrA2 is also able to induce apoptosis in human 
cells  in  a  caspase-independent  protease  pathway 
(Verhagen et al., 2002). Previous studies have dem-
onstrated  that  apoptosis  is  involved  in  ischemia/
reperfusion renal injuries (Zhao et al., 2009). Re-
cent studies from several different researchers have 
independently demonstrated that Omi/HtrA2 plays 
an important role in ischemia/reperfusion injuries. 
Althaus et al. (Althaus et al., 2007) reported that fo-
cal cerebral ischemia/reperfusion results in Omi/
HtrA2 translocation from the mitochondria to the 
cytosol, where it participates in neuronal cell death. 
Prior to ischemia, treatment with Ucf-101, the spe-
cific inhibitor of Omi/HtrA2, reduced both the in-
farct size and the number of apoptotic cells in the 
focal cerebral ischemia/reperfusion in animal mod-
els.  Hui-Rong  Liu  and  colleagues  demonstrated 
that myocardial ischemia/reperfusion significantly 
increased cytosolic Omi/HtrA2 content and mark-
edly increased  apoptosis  (Liu  et  al.,  2005).  Omi 
promotes cardiomyocyte apoptosis via a protease 
activity-dependent,  caspase-mediated  pathway. 
Treatment with Ucf-101 exerts significant cardio-
protective effects. The aim of the present study was 
to investigate the effect of Omi/HtrA2 on the renal 
injury that occurs in postasphyxial neonates and to 
explore further the mechanisms involved.
MATERIALS AND METHODS
Cell culture
Human kidney proximal tubular cell line (Ameri-
can  Type  Culture  Collection  )  HK-2  cells  were 
grown in DMEM (GIBCO, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (FBS) (Hy-
clone, Logan, UT), 50 U/ml penicillin, 50 µg/ml 
streptomycin (GIBCO),  and  15  mM  HEPES,  at 
37°C in an atmosphere of 95% air and 5% CO2. 
The cells were passaged weekly by trypsinization 
(0.25% trypsin, 0.02% EDTA) after formation of a 
confluent monolayer. The cultured cells were placed 
in serum-free media 24 h before stimulation and 
were divided into a control group, a postasphyxial 
serum-attacking group, and a ucf-101 group. The 
cells of the control group were grown in a normal 
nutritive medium. The cells of the postasphyxial 
serum-attacking group were grown in a medium 
with 20% postasphyxial serum. The cells of the ucf-
101 group were treated with ucf-101 (10 µmol/L) 
and  grown  in  20%  postasphyxial  serum.  During 
the preliminary study, we only examined the con-
trol group and the postasphyxial serum-attacking 
group to investigate whether Omi/HtrA2 was in-
volved in postasphyxial serum-induced injury to 
the human kidney proximal tubular cell line HK-2 
cells. In the next stage of our study, we included 
the ucf-101 group to determine the intracellular 
signal transduction pathway of Omi/HtrA2 in such 
injuries. Cells from all groups were harvested and 
assayed after 24 h of treatment.
Preparation of postasphyxial-serum in neonates
Neonates (mean gestational age, 37-40 weeks) with 
neonatal asphyxia (Apgar score lower than 7 points 
at 1 minute) admitted to our neonatal intensive care 
unit (NICU) between March 2007 and December 
2007 were enrolled in this study. The parents of the 
neonates gave informed consent for their partici-
pation. None of the patients was administered im-
mune depressants or exposed to infectious disease. 
Blood was aspirated from the femoral vein within 
24 h of birth (5 ml from each, anticoagulated using 
Liquemine, about 100 ml in total), then the serum 
was  gathered  by  3000  rpm  centrifugation  for  20 
min. The serum was inactivated in a thermostatic 
water bath at 56°C. The serum was filtered and ad-
justed to 200 ml/L by DMEM medium (Zhao et al., 
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Determination of cell viability
Cell viability was determined by MTT assay. Expo-
nentially growing HK-2 cells from each group were 
seeded in 96-well culture plates in serum-free me-
dium at optimal density. After 24 h of incubation, the 
cells were treated as described above. After 24 h, 20 
µl (5 g/L) MTT (Sigma) solution was added to each 
well. After 4 h of incubation, the supernatant was re-
moved and 150 µl DMSO was added to each well and 
swung for 10 min. The optical density at 590 nm was 
determined with an enzyme-linked immunosorbent 
assay (ELISA) reader. The results were calculated as 
mean values of eight wells per treatment group.
Detection of the expression of Omi/HtrA2 and 
 caspase-3
The expression of Omi/HtrA2 and caspase-3 in cyto-
plast was detected by SP immunocytochemical stain-
ing. Immunostaining was carried out according to 
the standard procedure (SP) and the manufacturer’s 
instructions. Cells were incubated overnight with the 
primary antibody at 4°C. The same process with PBS 
instead of the primary antibody was used as a con-
trol. After incubation with the secondary antibody 
at 37°C for 10 min and DAB staining, the cells were 
mounted  and  observed  under  a  microscope.  Five 
high-power fields were randomly selected. The posi-
tive cells appeared brownish-yellow in the cytoplast 
area. The expression of Omi/HtrA2 was determined 
by counting the number of positive cells among 200 
cells. The expression of caspase-3 was analyzed with 
the Image-Pro Plus 6.0 Image Analyzing System.
Confocal microscopy for Omi/HtrA2 translocation
Cells cultured on glass cover slips in orifice were 
incubated with MitoTracker Red 580 (1:50000 dilu-
tion) for 20 min at 37°C in the dark. Then cells were 
fixed on cover slips with 4% paraformaldehyde (15 
min, room temperature) and washed with PBS fol-
lowed by a permeabilization step with 0.1% Triton 
X-100 in PBS for 15 min at room temperature. After 
several washes with PBS, the cover slips were incu-
bated sequentially with blocking buffer for 20 min 
at room temperature), an anti-human Omi/HtrA2 
rabbit polyclonal antibody for 1 h at 37°C (5µg/
mL), and secondary antibody (goat anti-Rb IgG/
FITC) diluted in blocking buffer (1:150) for 30 min 
at 37°C in the dark. The cover slips were washed 
with  PBS  several  times  and  mounted  onto  glass 
slides (VWR) using glycerin. Omi/HtrA2 translo-
cation was observed by confocal microscopy. The 
images were acquired in the confocal microscope at 
excitation and emission wavelengths of 579 nm and 
495 nm, respectively.
Flow cytometric analysis of cell apoptosis
Cell apoptosis was determined by flow cytometry af-
ter staining with propidium iodide (PI). HK-2 cells 
(at least 1×106 per sample) from each group were 
harvested by trypsinization (0.25% trypsin), washed 
in PBS, and fixed in 70% pre-cooled ethanol. The 
tubes containing the cells were stored at 4°C for 24 
h. The cells were washed by centrifugation at 2000 
rpm for 5 min in PBS and stained with PI solution 
(0.05g/L, 5g/L RNase A, 10g/L Triton X-100) in the 
dark for 40 min at 37°C. Cells were then resuspended 
in PBS and centrifuged at 2000 rpm for 5 min before 
being resuspended in 500 μl PBS for flow cytometric 
analysis.
Statistical analyses
All  parameters  were  presented  as  mean±SEM  (x
±S). The translocation and expression of Omi/HtrA2 
between the groups were analyzed via the T test. The 
other data among the groups were analyzed using 
a one-way ANOVA followed by a mean compari-
son using a post hoc LSD test. Probabilities of 0.05 
or less were considered statistically significant. The 
statistical analyses were performed using SPSS 10.0 
software.
RESULTS
Changes in morphology and viability of HK-2 cells
Under inverted microscopy, HK-2 cells from the 
control  group  showed  normal  morphology  with 1508 YONG ZHANG ET AL.
tight connections to neighboring cells (Fig. 1A). 
Compared to those of the control group, the cells 
from  the  postasphyxial  serum-attacking  group 
changed from typical multy-ang applan to off-nor-
mal round or ellipse. The refraction rate was lower 
and contour enhanced. Vacuoles, lipid droplets and 
granulation appeared in the cytoplasm. There was a 
great deal of cell debris in the accrescent intercel-
lular space (Fig. 1B). Relative to those of the pos-
tasphyxial serum-attacking group, the changes in 
the morphology of the HK-2 cells of the ucf-101-
treated group were clearly improved (Fig. 1C).
Relative to the control group (0.47±0.02), the cell 
viability (optical density, OD) was significantly de-
creased in the postasphyxial serum-attacking group 
(0.22±0.02). Relative to the postasphyxial serum-at-
tacking group, cell viability was clearly increased in 
the ucf-101-treated group (0.36±0.02, P<0.05), but 
not to the same level as the control group (Fig. 2). 
Effects of postasphyxial-serum on Omi/HtrA2  
expression in HK-2 cells
Several  studies  have  reported  that  Omi/HtrA2 
plays  an  important  role  in  post-ischemic  organ 
             A                  B                C
                      A                B   
Fig. 1. The effect of Ucf-101 on the morphology of HK-2 cells treated with postasphyxial serum (inverted microscopy ×400). A. Control 
group; B. Postasphyxial serum-attacking group; C. Ucf-101-treated group.
Fig. 2. The effect of postasphyxial serum on the cell viability of 
HK-2 cells. Cell viability was determined by MTT assay. The 
control group shows the highest cell viability of all three groups. 
After  postasphyxial  serum  challenge,  the  cell  viability  of  the 
control group decreased remarkably but was partly reversed by 
treatment with ucf-101.
Fig. 3. Postasphyxial serum-induced changes in expression of 
Omi/HtrA2 in HK-2 cells. The level of expression of Omi/HtrA2 
was here detected by SP immunocytochemical staining. The per-
centage of cells expressing Omi/HtrA2 is small in the control 
group (Fig. A). After postasphyxial serum challenge, the per-
centage of postasphyxial serum-attacking-group cells expressing 
Omi/HtrA2 increased significantly (Fig. B).OMI/HTRA2 AND POSTASPHYXIAL RENAL INJURY 1509
injury (Bhuiyan and Fukunaga, 2007; Saito et al., 
2004). Following ischemia/reperfusion in the kid-
ney, the proteolytic activity of Omi/HtrA2 is mark-
edly upregulated (Faccio et al., 2000). To investigate 
whether Omi/HtrA2 was involved in postasphyxial 
serum-induced injury to HK-2 cells, we examined 
the level of expression of Omi/HtrA2 in HK-2cells 
by SP immunocytochemical staining. As shown in 
Fig. 2, Omi/HtrA2 was stained inaurate or yellow-
brown and appeared localized in the cytoplasm. The 
percentage of control-group cells expressing Omi/
Htra2 was 9.00±2.50% (Fig. 3A). After postasphyxi-
al serum challenge, the percentage of postasphyxial 
serum-attacking-group  Omi/Htra2-positive  cells 
increased remarkably (25.15±3.50%, P < 0.05) (Fig. 
3B).
Effects of postasphyxial-serum on Omi/HtrA2  
translocation from mitochondria to cytoplasm
The mature form of Omi/HtrA2 is localized in the mi-
tochondria and may have a distinct function involved 
in  the  maintenance  of  mitochondrial  homeostasis 
(Jones et al., 2003). In the cytoplasm, mature Omi/
HtrA2 can induce apoptosis in human cells either in 
a caspase-independent manner through its protease 
activity or in a caspase-dependent manner. The key 
step in this apoptotic pathway is the release of Omi/
Htra2 from the mitochondrial intermembrane space. 
To confirm that the Omi/HtrA2 protein is translo-
cated from mitochondria to cytoplasm in HK-2 cells 
treated with postasphyxial serum, we compared the 
fluorescence-staining  pattern  of  cells  stained  with 
             A1                  B1                C1
             A2                  B2                C2
Fig. 4. The effects of postasphyxial serum on the translocation of Omi/HtrA2 in human renal tubular cell (HK-2). Confocal microscope 
images of HK-2 cells (1. Control group, 2. postasphyxial serum-attacking group) stained with anti-Omi/HtrA2 (green) and MitoTracker 
Red 580 (red). Merged images from A1 and B1 are shown in C1. A2 and B2 are shown in C2. In the control group, Omi/HtrA2 protein 
staining colocalized with MitoTracker staining (C1). After exposure to postasphyxial-serum, the two staining patterns were distinctive 
(C2).1510 YONG ZHANG ET AL.
Omi/HtrA2  antibodies and  MitoTracker  Red  580. 
The results of the two staining patterns were almost 
identical in the control group,  indicating that Omi/
HtrA2 is localized predominantly in the mitochon-
dria in normal HK-2 cells (Fig. 4C1). The two stain-
ing patterns were distinctive in the postasphyxial se-
rum-attacking group, indicating that Omi/HtrA2 is 
translocated from the mitochondrial intermembrane 
space to the cytoplasm (Fig. 4C2).
Effects of postasphyxial serum on apoptosis 
 in HK-2 cells
Apoptosis plays an important role in the pathogen-
esis of a variety of ischemia/reperfusion (I/R) inju-
ries. We postulate that apoptosis is associated with 
postasphyxial serum-induced injury to HK-2 cells. 
Apoptosis of HK-2cells was evaluated by the quan-
titative determination of apoptosis using flow cyto-
metric  DNA  analysis  following  propidium  iodide 
(PI) staining. The data are presented as the percent-
age of apoptotic cells. As shown in Fig. 4, the pro-
portion of cells undergoing apoptosis increased from 
fewer than 15% in the control group (Fig. 5A) to 36% 
after being attacked by postasphyxial serum (Fig. 5B, 
P<0.05). The proportion of cells undergoing apopto-
sis decreased from 36% in the postasphyxial serum-
attacking group to 26% after ucf-101 treatment (Fig. 
5C, P<0.05). 
The effect of postasphyxial serum on caspase-3 
 expression in HK-2 cells
The  caspase  family  is  closely  connected  with 
many apoptotic processes. Caspase-3 is a common 
executioner of apoptosis (Thornberry and Lazebnik, 
1998). Multiple lines of evidence have demonstrated 
that caspase-3 plays a vital role in I/R injury. To con-
firm that caspase-3 participates in postasphyxial se-
rum-induced injury to HK-2, we examined the level 
of expression of caspase-3 in HK-2cells. As shown 
in Fig. 5, caspase-3 was inaurate or yellow-brown 
and  appeared  localized  in  the  cytoplasm  of  HK-
2cells. After being attacked by postasphyxial serum, 
the level of expression of caspase-3 was significantly 
increased, as indicated by the stronger staining in 
the postasphyxial serum-attacking group (Fig. 6B) 
relative to the control group (Fig. 6A, P<0.01). After 
treatment with ucf-101 (10µmol/L), the expression 
of  caspase-3  was  significantly  decreased  (Fig.  6C) 
relative to the postasphyxial serum-attacking group 
(P<0.05).
DISCUSSION
It has been reported that ischemia/reperfusion in-
duces  apoptosis  in  many  cells  through  different 
mechanisms. As a mitochondrial serine protein, ma-
ture Omi/HtrA2 is localized in the mitochondria. 
                A                     B                    C
Fig. 5. The effect of postasphyxial serum on apoptosis in HK-2 cells.HK-2 cell apoptosis was detected by flow cytometry. The proportion 
of cells undergoing apoptosis is small in the control group (Fig. A).The proportion of cells undergoing apoptosis increased significantly 
in the postasphyxial serum-attacking group (Fig.B). Relative to the postasphyxial serum-attacking group, the proportion of cells under-
going apoptosis decreased significantly in the group treated with ucf-101 (Fig.C).OMI/HTRA2 AND POSTASPHYXIAL RENAL INJURY 1511
Once released into the cytosol following activation 
of apoptotic stimuli, it promotes cell death by antag-
onizing IAPs (in a caspase-dependent fashion) and 
via its proteolytic activity (in a caspase-independent 
fashion) (Saelens et al., 2004). Several studies have 
demonstrated  that  overexpression  of  Omi/HtrA2 
markedly increases apoptosis (Kim et al., 2010; Tun 
et  al.,  2007).  In  this  study,  we  demonstrated  that 
postasphyxial-serum  incubation  can  significantly 
induce apoptosis in human HK-2 cells and that this 
effect is mediated by the overexpression and mito-
chondrial release of the Omi/HtrA2 protein into the 
cytoplasm. 
Omi/HtrA2  is  a  member  of  the  HtrA  serine 
protease protein family which shows extensive ho-
mology to the Escherichia coli HtrA genes that are 
essential for bacterial survival at high temperatures. 
The serine protease Omi/HtrA2 is synthesized as a 
precursor (premature Omi/HtrA2) and translocated 
into the mitochondria. Upon apoptotic stimuli, the 
N-terminal amino acids preceding alanine 134 are 
cleaved and the resulting mature Omi/HtrA2 is re-
leased from the mitochondria into the cytoplasm, 
where it induces apoptosis (Suzuki et al., 2004). Tran-
scription of Omi/HtrA2 has been shown to be upreg-
ulated in ischemic human kidneys. The enzymatic 
activity of Omi/HtrA2 is substantially enhanced in 
ischemic/reperfusing mouse kidneys (Faccio et al., 
2000). Here, we demonstrated that Omi/HtrA2 was 
overexpressed in HK-2 cells after these cells are at-
tacked by postasphyxial serum. Arnold Levine and 
colleagues have identified Omi/HtrA2 as a p53-tar-
geted gene (Jin et al., 2003). Kelly et al reported that 
p53 protein levels increase significantly in the kid-
ney over 24 h post-ischemia (Kelly et al., 2003). In 
postasphyxial serum-treated HK-2 cells, activation 
of the p53 protein increases the transcription of the 
Omi/HtrA2 gene. 
The key step in the role that Omi/HtrA2 plays 
in postasphyxial serum-induced HK-2 cell apoptosis 
is its release from the mitochondrial intermembrane 
space. After I/R injury, Ca2+ influx through the L-
type calcium channel triggers Ca2+ release from the 
InsP3R, which activates a cascade of Ca2+ release 
from the ER storage area (Wu et al., 2008). However, 
in ischemia/reperfusion injuries, severe depletion of 
ATP leads to failure of the pump-leak balance mech-
anism, leading to an influx of Na+ that results in an 
overload of Na+ in the cytosol. This increased Na+ 
level activates Na+-K+-ATPase and consumes ATP, 
                A                     B                    C
Fig. 6. The effect of postasphyxial serum on the expression of Omi/HtrA2 in HK-2 cells. The expression of caspase-3 was detected by SP 
immunocytochemical staining. The proportion of the cells expressing caspase-3 was small in the control group (Fig. A). After postas-
phyxial serum challenge, the percentage of cells expressing caspase-3 increased remarkably, as shown in this image of the postasphyxial 
serum-attacking group (Fig. B). After ucf-101 treatment, the percentage of cells expressing caspase-3 decreased remarkably (Fig. C) but 
not to the level of the control group. 1512 YONG ZHANG ET AL.
which further activates nonselective Ca2+ channels, 
resulting in massive cytosolic Ca2+ accumulation. 
Increased  cytoplasmic  Ca2+  may  activate  calpain, 
and calpain can cleave Bid (Chen et al., 2001b). Af-
ter cleavage, the truncated C-terminal portion of Bid 
(tBid) translocates to the mitochondria and is insert-
ed into the outer membrane via its tail. It then binds 
to Bax, facilitating its insertion into the outer mito-
chondrial membrane, and creates pores (Eskes et al., 
2000). In addition, monomeric Bax and tBID togeth-
er can induce lipid remodeling following the per-
meabilization of the outer mitochondrial membrane 
(Kuwana et al., 2002). Furthermore, full-length Bid 
may directly translocate to the mitochondria, where 
it may cause effects similar to those of Bax (Pei et al., 
2007; Verhagen et al., 2002). As the permeability of 
the outer mitochondrial membrane increases, Omi/
HtrA2 is released from the mitochondria to the cy-
toplasm.
TNF-α may also play an important role in the 
translocation  of  Omi/HtrA2  from  the  mitochon-
dria to the cytoplasm. In renal ischemia/reperfusion, 
TNF-α gene transcription is primarily regulated by 
NF-κB activation (Donnahoo et al., 2000). Usually, 
NF-κB is localized in the cytoplasm in an inactive 
state due to its association with a class of inhibi-
tory  proteins  termed  inhibitory  κB  (IκB).  During 
cellular ischemia/reperfusion injury, the phosphor-
ylation and subsequent ubiquitination of IκB leads 
to the release and nuclear translocation of NF- B, 
where it promotes the transcription of genes such 
as TNF-α (Chen et al., 2001a). Recent studies have 
demonstrated that TNF-α involves a sequential sig-
naling complex termed “complex I,” which contains 
TNFR-associated  factor  2  (TRAF2)  and  promotes 
the activation of the cytoprotective transcription fac-
tor NF-κB (Micheau and Tschopp, 2003). When NF-
κB is activated by complex I, a positive feedback for 
TNF-α gene transcription is formed. On one hand, 
TNF-α-induced oxidative stress alters redox home-
ostasis by impairing the MPTP protein adenine nu-
cleotide  translocator  and  voltage-dependent  anion 
channel, thereby resulting in the opening of pores 
and inducing the release of Omi/HtrA2 (Mariappan 
et al., 2007). On the other hand, the increased TNF-α 
level in the cytosol activates caspase-8, a proximal ef-
fector protein from the tumor necrosis factor recep-
tor family (TNFR). Even small amounts of activated 
caspase-8 are able to cleave Bid efficiently, the trun-
cated form of which translocates to the mitochon-
dria and induces the release of Omi/HtrA2 through 
the mechanism described above.
After  being  released  from  the  mitochondria, 
Omi/HtrA2 may play an important role in apoptosis 
by means of binding and cleaving IAP proteins and 
relieving their inhibitory effect on caspases (Ver-
hagen et al., 2007; Yang et al., 2003). The protease 
activity  of  Omi/HtrA2  is  central  to  its  function. 
Ucf-101, a specific Omi/HtrA2 inhibitor, is able to 
inhibit the protease activity of Omi/HtrA2 (Kim et 
al., 2010). Here we report that HK-2 cells treated 
with Ucf-101 are resistant to postasphyxial serum-
induced cell apoptosis. Our data demonstrate that 
Omi/HtrA2 plays a significant role in postasphyxial 
serum-induced HK-2 cell apoptosis and that its ser-
ine protease activity is necessary and essential for 
its proapoptotic function in this system. The role 
of Omi/HtrA2 in the cytoplasm is associated with 
caspase-3.  Many  researchers  have  demonstrated 
that caspase-3 is upregulated in organs affected by 
ischemia/reperfusion injury (Li et al., 2008; Teruya 
et al., 2008). Our results demonstrate that the level 
of expression of caspase-3 is upregulated in HK-2 
cells  attacked  by  postasphyxial  serum.  Caspase-3 
can also cleave and activate Bid after the onset of 
apoptosis as part of a positive feedback loop (Slee 
et al., 2000). HK-2 cells treated with ucf-101 are re-
sistant to postasphyxial serum-induced caspase-3 
expression. Our findings suggest that Omi/HtrA2 is 
associated with the expression of caspase-3 in HK-2 
cells treated with postasphyxial serum. 
Our studies suggest that Omi/HtrA2 may play 
an important role in neonatal postasphyxial serum-
induced injury in renal tubular cells. After HK-2cells 
were  attacked  by  neonatal  postasphyxial  serum, 
Omi/HtrA2 was released from the mitochondria to 
the cytoplasm, where it induced caspase-dependent 
apoptosis in the HK-2 cells through its proteolytic 
activity. Our findings may suggest a new way of re-OMI/HTRA2 AND POSTASPHYXIAL RENAL INJURY 1513
lieving postasphyxial serum injuries to human kid-
ney cells through inhibition of the proteolytic viabil-
ity of Omi/HtrA2.
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